NURIX THERAPEUTICS INC shareholders Q2 2023

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 126 filers reported holding NURIX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

NURIX THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 5,483$54,7750.00%
VOYA INVESTMENT MANAGEMENT LLC 30,072$300,4190.00%
ROYAL BANK OF CANADA 5,804$58,0000.00%
FMR LLC 416,613$4,161,9640.00%
BARCLAYS PLC 68,991$6900.00%
Bank of New York Mellon Corp 165,470$1,653,0460.00%
JANE STREET GROUP, LLC 38,707$386,6830.00%
Citadel Advisors 124,900$1,247,7510.00%
Citadel Advisors 12,300$122,8770.00%
Citadel Advisors 15,466$154,5050.00%
GREAT WEST LIFE ASSURANCE CO /CAN/ 1,891$190.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 93,300$932,0670.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,200$101,8980.00%
Legal & General Group Plc 32,538$325,0540.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 90,881$907,9010.00%
JPMORGAN CHASE & CO 52,827$527,7420.00%
LAZARD ASSET MANAGEMENT LLC 8,660$860.00%
JANUS HENDERSON GROUP PLC 12,923$129,0380.00%
NATIXIS 5,779$57,7320.00%
NOMURA ASSET MANAGEMENT CO LTD 0$00.00%
External links

This page lists NURIX THERAPEUTICS INC's shareholders in Q2 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.